|Articles|April 8, 2012

What Does Overturning ACA Mean to Pharma?

In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation.

Guest blog written by Reid Paul.

In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation. Given the strong support the bill originally received from the industry, does overturning it benefit or hurt pharma?

Video: Pharma and the Supreme Court reconsider healthcare reform

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

What Does Overturning ACA Mean to Pharma?

Related Content

Maintaining a Strong Company Culture Through Difficult Times

Congress Leaves Town with Major Drug-Related Bills on Hold

Large Clinical Trial Supports Alzheimer Drug Full Approval

Long-Admired PEPFAR Program Caught in Abortion Debate

Medicare Still Won’t Pay for Alzheimer’s Drugs without Confirmatory Data

Trending on Pharmaceutical Technology

FDA Guidance for Accelerating Gene Therapies for Rare Diseases

Implications of Pediatric Inhaled Insulin Approval

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance

Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs

Generic GLP-1s Enter Canadian Market